Chinese researcher dismissed after concealing child's death in gene therapy trial
Published 1 d ago2 sourcesEvidence: Reported
A new startup has secured $173 million in funding to develop a sickle cell treatment that aims to match gene therapy's efficacy without its drawbacks. The approach is early-stage and unproven, but the funding signals investor interest in alternatives to costly gene therapies. The development is notable for the biotech sector but has no immediate market-wide impact.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 1 d ago2 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago3 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 15 h ago1 sourceEvidence: Reported
Published 16 h ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago7 sourcesEvidence: Reported